Protokoll: GM-IMAB-002-01
Laufzeit: 01.01.2015 - 31.12.2017
imported
Kurzfassung
A first-in-human dose escalation and dose finding phase I/II trial of IMAB027 in patients with recurrent advanced ovarian cancer
Laufzeit: 01.01.2015 - 31.12.2017
A first-in-human dose escalation and dose finding phase I/II trial of IMAB027 in patients with recurrent advanced ovarian cancer